InvestorsHub Logo
Followers 38
Posts 5184
Boards Moderated 2
Alias Born 08/05/2002

Re: Samsa post# 25212

Friday, 03/17/2017 1:03:11 PM

Friday, March 17, 2017 1:03:11 PM

Post# of 38634
Oh Samsa,

You are starting to sound like me ..... I must be rubbing off on you.

I too am wondering what they are doing. If they want final approval to launch Rexista in September, they need to get a partner lined up now.

Along the manufacturing lines ..... also has me wondering about Seroquel. All I get out of them is "that is the plan" as it relates to launching in May. They have indicated an update would be offered with the F1Q earnings report. May 1 is just over 6 weeks away. I expect they will have to be inspected and producing test batches by now to be in line for final approval to launch May 1. Although I also believe they are already FDA approved site and surely produced test batches in the past.

You and others keep talking about Focalin and Seroquel revenues getting us to CF+ and all .... and I get that ..... but the problem is that is based on the burn NOW .... and not what it would be if I had some money in my pocket. With some cash flow from those products, I would expect that to be immediately spent on more R&D to advance PODRAS and other candidates. So yes I agree it will bring more cash .... but cash that will be spent on further development.

IPCI needs to land partnership for Regabatin and PODRAS development and they need to get it done sooner rather than later.

Amigo Mike